Combined Post- and Precapillary Pulmonary Hypertension in Patients With Heart Failure

被引:23
|
作者
Rezaee, Michael E. [1 ,2 ]
Nichols, Elizabeth L. [2 ]
Sidhu, Mandeep [3 ]
Brown, Jeremiah R. [2 ,4 ,5 ]
机构
[1] Oakland Univ, Beaumont Sch Med, Internal Med, Rochester, MI 48063 USA
[2] Geisel Sch Med, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA
[3] Albany Med Ctr, Div Cardiol, Albany, NY USA
[4] Dartmouth Hitchcock Med Ctr, Dept Med, Lebanon, NH 03766 USA
[5] Dept Community & Family Med, Lebanon, NH USA
关键词
Pulmonary hypertension; Heart failure; cardiac transplantation; cardiomyopathy; myocarditis; Epidemiology; PRESERVED EJECTION FRACTION; ARTERIAL CAPACITANCE; PRESSURE-GRADIENT; PREDICTOR; MORTALITY; DISEASE; TARGET;
D O I
10.1002/clc.22579
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundPulmonary hypertension (PH) is a well-recognized complication of left ventricular heart failure (HF). HypothesisDifferences exist in demographic, clinical, hemodynamic, and survival characteristics of patients with left ventricular HF who have combined postcapillary and precapillary PH (CpcPH), isolated postcapillary PH, or no PH. MethodsA secondary data analysis was conducted using a large prospective database of patients undergoing right heart catheterization from 1994 to 2012. One-year mortality postcatheterization was assessed between PH groups using Kaplan-Meier and log-rank techniques, as well as a multivariate Cox proportional hazards model adjusted for age, sex, diabetes, chronic kidney disease, atrial fibrillation, and chronic obstructive pulmonary disease. Mortality rates were calculated for each group as deaths per 100 person-years. ResultsOf the 724 patients identified, 29.4% (n=213) had no evidence of PH, 63.1% (n=457) had isolated postcapillary PH, and 7.5% (n=54) had CpcPH. Compared with no PH, there was an increased mortality rate within 1 year for CpcPH patients (crude hazard ratio: 5.22, 95% confidence interval: 2.06-13.22), but not for isolated postcapillary PH patients (crude hazard ratio: 2.12, 95% confidence interval: 0.99-4.57). Adjusted analyses revealed similar results. Mortality rates per 100 person-years were 3.9, 8.4, and 21.0 for no PH, isolated postcapillary PH, and CpcPH patients, respectively. ConclusionsHeart failure patients with CpcPH are associated with increased death rate 1 year post-cardiac catheterization, compared with patients without PH. They are a high-risk PH group and should be evaluated and diagnosed earlier in the disease state.
引用
收藏
页码:658 / 664
页数:7
相关论文
共 50 条
  • [31] Combined post- and pre-capillary pulmonary hypertension in heart transplant candidates with ischemic versus nonischemic etiology
    Bayram, Z.
    Dogan, C.
    Acar, R. D.
    Guvendi, B.
    Karaduman, A.
    Unkun, T.
    Akbal, O. Y.
    Hakgor, A.
    Uysal, S.
    Kaymaz, C.
    Ozdemir, N.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 222 - 222
  • [32] Sildenafil for This Heart Failure With a Preserved Ejection Fraction? Diastolic Dysfunction and Gerbode Defect Induced Combined Precapillary and Postcapillary Pulmonary Hypertension
    Franco-Palacios, Domingo
    Kicker, Patrick
    Shlobin, Oksana
    Zhao, Qiong
    Gomberg-Maitland, Mardi
    [J]. CHEST, 2017, 152 (04) : 1026A - 1026A
  • [33] Clinical and Biological Insights Into Combined Post- and Pre-Capillary Pulmonary Hypertension
    Assad, Tufik R.
    Hemnes, Anna R.
    Larkin, Emma K.
    Glazer, Andrew M.
    Xu, Meng
    Wells, Quinn S.
    Farber-Eger, Eric H.
    Sheng, Quanhu
    Shyr, Yu
    Harrell, Frank E.
    Newman, John H.
    Brittain, Evan L.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (23) : 2525 - 2536
  • [34] Therapeutic potential of phosphodiesterase 5 inhibitors in patients with heart failure with preserved ejection fraction (HFpEF) and combined post- and pre-capillary pulmonary hypertension (Cpc-PH).
    Kramer, T.
    Orlova, K.
    Gerhardt, F.
    Dumitrescu, D.
    Ten Freyhaus, H.
    Baldus, S.
    Rosenkranz, S.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 531 - 531
  • [35] Airway Bypass Stents for Emphysema, Algorithm to Exclude Precapillary Pulmonary Hypertension, and Sildenafil for Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction
    Lammi, Matthew R.
    Panetta, Nicholas
    Vega, Maria Elena
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 185 (12) : 1323 - 1324
  • [36] LEFT VENTRICULAR FILLING RATE PREDICTS CLINICAL FAILURE IN PATIENTS WITH PRECAPILLARY PULMONARY HYPERTENSION
    Giannakoulas, George
    Mouratoglou, Sofia
    Kamperidis, Vasileios
    Pitsiou, Georgia
    Kallifatidis, Alexandros
    Hadjimiltiades, Stavros
    Karvounis, Haralampos
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1914 - 1914
  • [37] Approach to patients with heart failure and pulmonary hypertension
    Forfia P.R.
    [J]. Current Treatment Options in Cardiovascular Medicine, 2007, 9 (4) : 302 - 309
  • [38] Will we be singing a different tune on combined post- and pre-capillary pulmonary hypertension?
    Hsu, Steven
    Tedford, Ryan J.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 51 (02)
  • [39] Predictors of a precapillary component in patients with postcapillary pulmonary hypertension
    Fard, Damien
    Boucly, Athenais
    Preda, Mariana
    Montani, David
    Jais, Xavier
    Savale, Laurent
    Mignard, Xavier
    Jevnikar, Mitja
    Jutant, Etienne-Marie
    Seferian, Andrei
    Humbert, Marc
    Vachiery, Jean-Luc
    Sitbon, Olivier
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [40] DRUGS TRIAL IN PATIENTS WITH PRECAPILLARY PULMONARY-HYPERTENSION
    GRAD, A
    POHAR, B
    MOZINA, M
    HORVAT, M
    [J]. ZDRAVSTVENI VESTNIK, 1987, 56 (03): : 99 - 101